Definitive Contract W81XWH19C0048
Award Date
12/19/18
Potential Completion Date
5/1/20
Potential Value
$145K
Federal Agency
Medical Command
Awardee
Daxor Corporation
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AN91 - R&D- Medical: Other (Basic Research)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Oak Ridge, TN 37830, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
35
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded a $1,098,669.00 firm fixed price contract to Daxor Corporation, a self-certified small disadvantaged business and manufacturer of goods, for Phase II research and development under the Small Business Innovation Research (SBIR) program. The contract is for Daxor's proposal titled "Direct Blood Volume Analyzer for Improvement of Combat Casualty Care" and is intended to support the development of medical technologies related to hemorrhage...
This is a $1,649,996.73 firm-fixed-price contract awarded by the Defense Health Agency (DHA) to Daxor Corporation, a self-certified small disadvantaged business, for Phase II of the Small Business Innovation Research (SBIR) program. The contract, with a period of performance from July 2023 to November 2025, is for research and development related to hemorrhage treatment and blood volume analysis technologies to support combat casualty care. This contract is a set-aside for small businesses and...
This is a firm fixed price purchase order contract awarded by the Air Force Research Laboratory to Daxor Corporation, a small disadvantaged business, for the Far Forward and En Route Decision Assist in the Treatment of Hemorrhage under the Small Business Innovation Research (SBIR) Program Phase II. The contract has a ceiling value of $749,967.00 and is set to expire on August 15, 2024. Daxor Corporation, the prime contractor, is a medical instrumentation and biotechnology company that provides...
This is a $1,899,999.72 Firm Fixed Price purchase order awarded to Daxor Corporation, a self-certified small disadvantaged business, by the Air Force Research Laboratory (AFRL) under the Small Business Innovation Research (SBIR) Program Phase II. The contract is to develop and validate hardware and methods for the BVA-200F diagnostic, which is related to blood volume analysis. The work will be performed in Oak Ridge, Tennessee, with a period of performance ending on July 31, 2026. This...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $25,000.00 firm fixed price purchase order to Daxor Corporation, a self-certified small disadvantaged business, for preventive maintenance and repair services on a Daxor BVA-100 Blood Volume Analyzer. This sole source contract was awarded under Federal Acquisition Regulation (FAR) part 13.106-1(b) and has an ultimate completion date of August 31, 2028. Daxor Corporation is the...
This is a Definitive Contract awarded by the Defense Health Agency (DHA) to Delta Development Team, Inc., a self-certified small disadvantaged business, for a SBIR Phase II medical research and development project. The contract, valued at $1,626,949.54, is set aside for total small business participation. The contract calls for the development of a maturing battlefield whole blood logistics solution, medical equipment for national security efforts, and autonomous portable refrigeration units,...
<p>This is a $150,000.00 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Resusitech Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for a DHP SBIR PHASE I PROPOSAL H161-009-0159 and has a period of performance through April 14, 2017. This SBIR Phase I award was set aside for small businesses.</p>
The U.S. Defense Health Agency (DHA) awarded a $250,000.00 Small Business Innovation Research (SBIR) Phase I contract to Gand Inc., a for-profit medical research and development company based in Miami Beach, Florida. The contract is for a project titled "Manufactured Universal Whole Blood-Like Fluid" and is set aside for total small businesses. This award is part of the DHA's SBIR program, which funds feasibility studies, further research and development, and commercialization of...
<p>This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Health Agency (DHA) to Desicorp, Inc. for the development of a thermally stable whole blood product for transfusion. The contract has a firm fixed price of $249,957.36 and a completion date of January 17, 2021. As a Phase I SBIR award, this contract is focused on the initial research and feasibility exploration of the proposed technology. The contract was set aside for small businesses.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to JSL Innovations LLC, a small business, for the development of an Automated Hemorrhage Control Device. The contract has a ceiling value of $218,930.00 and a period of performance ending on March 25, 2022. The award was made on May 28, 2021 under a Broad Agency Announcement that sought proposals for SBIR and Small Business Technology Transfer (STTR) funding...